Ružić, Dušan

Type

Date issued

92 2000 - 2027

Mp-cat.

64 М30/М60
13 M21
4 M21a
4 M22
2 M21a+
1 M10/M40
1 M23
1 M52
1 M70
1 other
. next >

Date issued - custom

Year from:

Year to:

Results 21-40 of 92 Results/Page

Issue Date	Title	Author(s)	Type	Мp-cat.
2023	Computer-aided drug design of MAPK inhibitors by combined 3D-QSAR analysis and molecular docking	Čebzan, Alen ; Ružić, Dušan ; Nikolić, Katarina	Conference Paper	Mp. category will be shown later
2022	Design of Dual COX-2 and 5-LOX Inhibitors with Iron-Chelating Properties Using Structure-Based and Ligand-Based Methods	Bošković, Jelena ; Ružić, Dušan ; Čudina, Olivera ; Nikolic, Katarina ; Dobričić, Vladimir	Article	23M23
2022	Bistable Photoswitch Allows in Vivo Control of Hematopoiesis	Albert, Lea; Nagpal, Jatin; Steinchen, Wieland; Zhang, Lei; Werel, Laura; Đoković, Nemanja ; Ružić, Dušan ; Hoffarth, Malte; Xu, Jing; Kaspareit, Johanna; Abendroth, Frank; Royant, Antoine; Bange, Gert; Nikolić, Katarina ; Ryu, Soojin; Dou, Yali; Essen, Lars-Oliver; Vázquez, Olalla;	Article	21a+M21a+
2022	Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells	Bulut, Ipek; Lee, Adam; Cevatemre, Buse; Ružić, Dušan ; Belle, Roman; Kawamura, Akane; Gul, Sheraz; Nikolić, Katarina ; Ganesan, A.; Acilan, Ceyda	Article	21M21
2022	Novel protocol for enhanced sampling of binding pocket dynamics and its integration into the sirtuin 2 inhibitors virtual screening campaign	Đoković, Nemanja ; Ružić, Dušan ; Rahnasto‐Rilla, Minna; Srdić-Rajić, Tatjana ; Lahtela‐Kakkonen, Maija; Nikolić, Katarina	Conference Paper	Mp. category will be shown later
2022	Epigenetic drug discovery: fragment-based drug design of novel 1-benzhydryl-piperazine derivatives as selective histone deacetylase 6 inhibitors	Ružić, Dušan ; Đoković, Nemanja ; Srdić-Rajić, Tatjana ; Nikolić, Katarina	Conference Paper	Mp. category will be shown later
2022	Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies	Bon, Corentin; Barbachowska, Magdalena; Đoković, Nemanja ; Ružić, Dušan ; Si, Yang; Soresinetti, Laura; Jallet, Corinne; Tafit, Ambre; Halby, Ludovic; Nikolić, Katarina ; Arimondo, Paola B;	Article	21M21
2022	Design of novel dual COX 2 and 5 LOX inhibitors using quantitative structure activity relationships analysis	Bošković, Jelena ; Dobričić, Vladimir ; Ružić, Dušan ; Nikolić, Katarina ; Čudina, Olivera	Conference Paper	Mp. category will be shown later
2022	Anticancer evaluation of the selected tetrahydropyrimidines: 3D-QSAR, cytotoxic activities, mechanism of action, DNA, and BSA interactions	Milović Emilija ; Petronijević Jelena ; Joksimović Nenad ; Beljkaš M. ; Ružić D. ; Nikoletić Katarina ; Vraneš Milan ; Tot Aleksandar S. ; Đorđić Crnogorac Marija ; Stanojković Tatjana P. ; Janković Nenad ;	Article	22M22
2022	Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention	Ružić, Dušan ; Đoković, Nemanja ; Srdić-Rajić, Tatjana ; Echeverria, Cesar; Nikolić, Katarina ; Santibanez, Juan	Article	21aM21a
2022	Racionalni dizajn, sinteza i in vitro ispitivanja selektivnih inhibitora histon deacetilaze 6	Ružić, Dušan	Doctoral theses	70M70
2022	Identification of novel 1-benzhydryl-piperazine derivatives as Histone Deacetylase inhibitors using Fragment-based drug design strategy	Ružić, Dušan ; Ellinger, Bernhard; Đoković, Nemanja ; Santibanez, Juan ; Ganesan, A.; Pavić, Aleksandar; Srdić Rajić, Tatjana ; Petković, Miloš ; Nikolić, Katarina	Other	Mp. category will be shown later
2022	Computer-aided drug design and evaluation of selective inhibitors against cytoplasmic histone deacetylases	Ružić, Dušan ; Đoković, Nemanja ; Petković, Miloš ; Gul, Sheraz; Lahtela‐Kakkonen, Maija; Ganesan, A.; Nikolić, Katarina	Conference Paper	Mp. category will be shown later
2022	Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation	Ružić, Dušan ; Ellinger, Bernhard; Đoković, Nemanja ; Santibanez, Juan ; Gul, Sheraz; Beljkaš, Milan ; Đurić, Ana ; Ganesan, Arasu; Pavić, Aleksandar ; Srdić-Rajić, Tatjana ; Petković, Miloš ; Nikolić, Katarina ;	Article	21aM21a
2022	Rational design and in vitro evaluation of selective inhibitors of cytoplasmic histone deacetylases SIRT2 and HDAC6	Ružić, Dušan ; Đoković, Nemanja ; Petković, Miloš ; Gul, Sheraz; Lahtela‐Kakkonen, Maija; Ganesan, A.; Srdić-Rajić, Tatjana ; Nikolić, Katarina	Conference Paper	Mp. category will be shown later
2022	Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket Dynamics	Đoković, Nemanja ; Ružić, Dušan ; Rahnasto-Rilla, Mina; Srdić-Rajić, Tatjana ; Lahtela-Kakkonen, Maija; Nikolić, Katarina	Article	21aM21a
2021	Synthesis and biological activity of a cytostatic inhibitor of MLLr leukemia targeting the DOT1L protein	Bon, Corentin; Si, Yang; Pernak, Melanie; Barbachowska, Magdalena; Levi-Acobas, Eva; Cadet Daniel, Veronique; Jallet, Corinne; Ružić, Dušan ; Đoković, Nemanja ; Đikić, Teodora ; Nikolić, Katarina ; Halby, Ludovic; Arimondo, Paola B.;	Article	21M21
2021	Epigenetic drug discovery: Successful examples of Computer-Aided Drug Designing of Histone Deacetylase (HDAC6 and SIRT2) and Histone Methyltransferase (DOT1L) inhibitors	Ruzic, Dušan ; Đoković, Nemanja B. ; Bon C.; Petkovic, M. ; Ellinger B.; Gul, S.; Santibanez F. J.; Lahtela-Kakkonen, M.; Halby L.; Ganesan, A.; Srdic-Rajic T. ; Arimondo P.; Nikolić, Katarina M. ;	Conference Paper	Mp. category will be shown later
2021	Fragment-Based Drug Design of Selective HDAC6 Inhibitors	Ružić, PhD, Dušan	Book parts	Mp. category will be shown later
2021	An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main Protease	Đoković, Nemanja ; Ružić, Dušan ; Đikić, Teodora ; Cvijić, Sandra ; Ignjatović, Jelisaveta ; Ibrić, Svetlana ; Baralić, Katarina ; Buha-Đorđević, Aleksandra ; Ćurčić, Marijana ; Đukić-Ćosić, Danijela ; Nikolić, Katarina ;	Article	21M21